Suppr超能文献

8044 例 Merkel 细胞癌患者的原发肿瘤大小、受累淋巴结数量与生存的关系。

Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma.

机构信息

Department of Medicine/Dermatology, University of Washington, Seattle, Washington.

Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, Washington.

出版信息

J Am Acad Dermatol. 2014 Apr;70(4):637-643. doi: 10.1016/j.jaad.2013.11.031. Epub 2014 Feb 9.

Abstract

BACKGROUND

The effects of primary tumor size on nodal involvement and of number of involved nodes on survival have not, to our knowledge, been examined in a national database of Merkel cell carcinoma (MCC).

OBJECTIVE

We sought to analyze a retrospective cohort of patients with MCC from the largest US national database to assess the relationships between these clinical parameters and survival.

METHODS

A total of 8044 MCC cases in the National Cancer Data Base were analyzed.

RESULTS

There was a 14% risk of regional nodal involvement for 0.5-cm tumors that increased to 25% for 1.7-cm (median-sized) tumors and to more than 36% for tumors 6 cm or larger. The number of involved nodes was strongly predictive of survival (0 nodes, 76% 5-year relative survival; 1 node, 50%; 2 nodes, 47%; 3-5 nodes, 42%; and ≥6 nodes, 24%; P < .0001 for trend). Younger and/or male patients were more likely to undergo pathological nodal evaluation.

LIMITATIONS

The National Cancer Data Base does not capture disease-specific survival. Hence, relative survival was calculated by comparing overall survival with age- and sex-matched US population data.

CONCLUSION

Pathologic nodal evaluation should be considered even for patients with small primary MCC tumors. The number of involved nodes is strongly predictive of survival and may help improve prognostic accuracy and management.

摘要

背景

据我们所知,在梅克尔细胞癌(MCC)的国家数据库中,尚未检查原发肿瘤大小对淋巴结受累的影响,以及受累淋巴结数量对生存的影响。

目的

我们试图分析美国最大的国家数据库中 MCC 患者的回顾性队列,以评估这些临床参数与生存之间的关系。

方法

对国家癌症数据库中的 8044 例 MCC 病例进行了分析。

结果

0.5cm 肿瘤的区域淋巴结受累风险为 14%,而 1.7cm(中位大小)肿瘤的受累风险增加到 25%,6cm 或更大的肿瘤的受累风险超过 36%。受累淋巴结的数量与生存密切相关(0 个淋巴结,5 年相对生存率为 76%;1 个淋巴结,50%;2 个淋巴结,47%;3-5 个淋巴结,42%;≥6 个淋巴结,24%;趋势 P<0.0001)。年轻和/或男性患者更有可能接受病理淋巴结评估。

局限性

国家癌症数据库无法捕获疾病特异性生存情况。因此,通过将总体生存与年龄和性别匹配的美国人群数据进行比较,计算相对生存率。

结论

即使对于患有小的原发性 MCC 肿瘤的患者,也应考虑进行病理淋巴结评估。受累淋巴结的数量与生存密切相关,可能有助于提高预后准确性和管理。

相似文献

9

引用本文的文献

1
Gross hematuria in an immunocompromised male - A case report.一名免疫功能低下男性的肉眼血尿——病例报告
Int J Surg Case Rep. 2025 Jun;131:111300. doi: 10.1016/j.ijscr.2025.111300. Epub 2025 Apr 18.

本文引用的文献

4
Features predicting sentinel lymph node positivity in Merkel cell carcinoma.预测 Merkel 细胞癌前哨淋巴结阳性的特征。
J Clin Oncol. 2011 Mar 10;29(8):1036-41. doi: 10.1200/JCO.2010.33.4136. Epub 2011 Feb 7.
10
Final version of 2009 AJCC melanoma staging and classification.2009 年 AJCC 黑色素瘤分期与分类的最终版。
J Clin Oncol. 2009 Dec 20;27(36):6199-206. doi: 10.1200/JCO.2009.23.4799. Epub 2009 Nov 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验